My approach to the immunogenetics of haematopoietic stem cell transplant matching

Journal of Clinical Pathology

Volumn 63, Issue 3, 2010, Pages 194-198

  Sage, Deborah ^a  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRAFT VERSUS HOST DISEASE; ALLELE; ANTIGEN DETECTION; ANTIGEN FUNCTION; DONOR SELECTION; GENE LOCUS; HAPLOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; HLA MATCHING; HLA SYSTEM; HUMAN; IMMUNOGENETICS; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; REVIEW; TREATMENT OUTCOME;

DONOR SELECTION; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; TISSUE AND ORGAN HARVESTING; TISSUE DONORS;

EID: 77749301554     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2009.068445     Document Type: Review

References (57)

1. Beatty PG, Clift RA, Mickelson EM, et al. Marrow transplantation from related donors other than HLA identical siblings. N Engl J Med 1985;313:765-71.
2. Anasetti C, Beatty PG, Storb R, et al. Effect of HLA incompatibility on graft-versus-host-disease, relapse, and survival after marrow transplantation for patients with leukemia or lymphoma. Hum Immunol 1990;29:79-91.
3. Davies SM, Shu XO, Blazar BR, et al. Unrelated donor bone marrow transplantation: influence of HLA-A and B incompatibility on outcome. Blood 1995;86:1636-42.
4. Spencer AP, Brookes PA, Kaminski E, et al. Cytotoxic T lymphocyte precursor frequency analyses in bone marrow transplantation with volunteer unrelated donors: value in donor selection. Transplantation 1995;59:1320-1308.
5. Kollman C, Howe CWS, Anasetti C, et al. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood 2001;98:2043-51.
6. Boeckh M, Nichols WG. The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy. Blood 2004;103: 2003-8.
7. Ferrara JL, Deeg HJ. Graft versus Host Disease. N Engl J Med 1991;324:667-74.
8. Ferrara GB, Bacigalupo A, Lamparelli T, et al. Bone marrow transplantation from unrelated donors: the impact of mismatches with substitutions at position 116 of the human leukocyte antigen class I heavy chain. Blood 2001;98:3150-5.
9. Glucksberg H, Storb R, Fefer A, et al. Clinical manifestations of graft versus host disease in human recipients of marrow from HL-A matched sibling donors. Transplantation 1974;18:295-304.
10. Horowitz M, Gale RP, Sondel PM, et al. Graft-versus- leukemia reactions after bone marrow transplantation. Blood 1990;75:555-62.
11. Beatty PG, Anasetti C, Hansen JA, et al. Marrow transplantation from unrelated donors for treatment of hematologic malignancies: effect of mismatching for one HLA locus. Blood 1993;81:249-53.
12. Sasazuki T, Juji T, Morishima Y, et al. Effect of mismatching of class I HLA alleles on clinical outcome after transplantation of haematopoietic stem cells from unrelated donors. New Engl J Med 1998;339:1177-85.
13. Morishima Y, Sasazuki T, Inoko H, et al. The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B and HLA-DR matched unrelated donors. Blood 2002;99:4200-6.
14. Petersdorf EW, Longton GM, Anasetti C, et al. The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation. Blood 1995;86:1601-13.
15. Petersdorf EW, Gooley TA, Anasetti C, et al. Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. Blood 1998;92:3515-20.
16. Petersdorf EW, Longton GM, Anasetti C, et al. Definition of HLA-DQ as a transplantation antigen. Proc Natl Acad Sci U S A 1996;93:15358-63.
17. Petersdorf EW, Longton GM, Anasetti C, et al. Association of HLA-C disparity with graft failure after marrow transplantation from unrelated donors. Blood 1997;89:1818-23.
18. Petersdorf EW, Gooley T, Malkki M, et al. The biological significance of HLA-DP gene variation in haematopoietic cell transplantation. Br J Haem 2001;112:988-94.
19. Loiseau P, Esperou H, Busson M, et al. DPB1 disparities contribute to severe GVHD and reduced patient survival after unrelated donor bone marrow transplantation. Bone Marrow Transplant 2002;30:497- 502.
20. Shaw BE, Marsh SG, Mayor NP, et al. HLA-DPB1 matching status has significant implications for recipients of unrelated donor stem cell transplants. Blood 2006;107:1220-6.
21. Shaw BE. The clinical implications of HLA mismatches in unrelated donor haematopoietic cell transplantation. Int J Immunogenet 2008;35:367-74.
22. Flomenberg N, Baxter-Lowe LA, Confer D, et al. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood 2004;104:1923-30.
23. Petersdorf EW, Anasetti C, Martin PJ, et al. Limits of HLA mismatching in unrelated hematopoietic cell transplantation. Blood 2004;104:2976-80.
24. Chalandon Y, Tiercy JM, Schanz U, et al. Impact of high-resolution matching in allegeneic unrelated donor stem cell transplantation in Switzerland. Bone Marrow Transplant 2006;37:909-16.
25. Ho VT, Kim HT, Liney D, et al. HLA-C mismatch is associated with inferior survival after unrelated donor non-myeloablative hematopoietic stem cell transplantation. Bone Marrow Transplant 2006;37:845-50.
26. Duarte RF, Pamphilon D, Cornish J, et al. Topical issues in unrelated donor haematopoietic stem cell transplants: a report from a workshop convened by the Anthony Nolan Trust in London e 2005. Bone Marrow Transplant 2006;37:901-8.
27. Lee SJ, Klein J, Haagenson M, et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood 2007;110:4576-83.
28. Bray R, Hurley CK, Kamani NR, et al. National marrow donor program HLA matching guidelines for unrelated adult donor hematopoietic cell transplants. Biol Blood Marrow Transplant 2008:14:45-53.
29. Heemskerk MB, van Walraven SM, Cornelissen JJ, et al. How to improve the search for an unrelated haematopoietic stem cell donor. Faster is better than more!. Bone Marrow Transplant 2005;35:645-52.
30. Tiercy J-M, Nicoloso G, Passweg J, et al. The probability of identifying a 10/10 HLA allele-matched unrelated donor is highly predictable. Bone Marrow Transplant 2007;40:515-22.
31. Hirv K, Bloch K, Fischer M, et al. Prediction of duration and success rate of unrelated hematopoietic stem cell donor searches based on the patient's HLA-DRB1 allele and DRB1-DQB1 haplotype frequencies. Bone Marrow Transplant. advance online publication 16 2009;44:433-40. doi:10.1038/bmt.2009.53.
32. Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 1992;39:225-35.
33. Bunce M, O'Neill CM, Barnardo MC, et al. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence specific primers (PCR-SSP). Tissue Antigens 1995;46:355-67.
34. Mickelson E, Smith A, McKinney S, et al. A comparative study of HLA-DRB1 typing by serology and hybridization of nonradioactive sequence specific oligonucleotide probes to PCR-amplified DNA. Tissue Antigens 1993;41:86-93.
35. Dunn PPJ, Day S, Williams S, et al. DNA sequencing as a tissue typing tool. In: Goulden N, Steward C, eds. Methods in molecular medicine Totowa, NJ: Humana Press, 2004;91:233-46.
36. Heinemann FM. HLA genotyping and antibody characterization using the LuminexTM multiplex technology. Transfus Med Hemother 2009;36:273-8.
37. Cano P, Klitz W, Mack SJ, et al. Common and well documented HLA alleles report of the Ad-Hoc committee of the american society for histocompatibility and immunogenetics. Hum Immunol 2007;68:392- 417.
38. Anasetti C, Amos D, Beatty PG, et al. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukaemia or lymphoma. N Engl J Med 1989;320:197-204.
39. Klingebiel T, Handgretinger R, Lang P, et al. Haploidentical transplantation for acute lymphoblastic leukemia in childhood. Blood Rev 2004;18:181-92.
40. Huang XJ. Current status of haploidentical stem cell transplantation for leukaemia. J Hematol Oncol 2008;1:27-35.
41. Ottinger H, Muller CR, Goldmann SF, et al. Second german consensus on immunogenetic donor search for allotransplantation of hematopoietic stem cells. Ann Hematol 2001;80:706-14.
42. Ottinger H, Grosse-Wilde M, Schmitz A, et al. Immunogenetic marrow donor search for 1012 patients: a retrospective analysis of strategies, outcome and costs. Bone Marrow Transplant 1994;14(Suppl 4):34-8.
43. Gluckman E, Broxmeyer HA, Auerbach AD, et al. Haematopoietic reconstitution in a patient with Faconi's anaemia by means of umbilical cod blood from an HLA identical sibling. N Engl J Med 1989;321:1174-8.
44. Sanz MA. Cord-blood transplantation in patients with leukaemia e a real alternative for adults. N Engl J Med 2004;351:2328-30.
45. Kamani N, Spellamn S, Hurley CK, et al. State of the art review: HLA matching and outcome of unrelated donor umbilical cord blood transplants. Biol Blood Marrow Transplant 2008:14:1-6.
46. Shaw BE, Veys P, Pagliuca A, et al. Recommendations for a standard UK approach to incorporating umbilical cord blood into clinical transplantation practice: conditioning protocols and donor selection algorithms. Bone Marrow Transplant 2009;44:7-12.
47. Petersdorf EW, Malkki M, Gooley TA, et al. MHC haplotype matching for unrelated hematopoietic cell transplantation. PLoS Med 2007;4:59-68.
48. Guo Z, Hood L, Malkki M, et al. Long-range multilocus haplotype phasing of the MHC. Proc Natl Acad Sci U S A 2006;103:6964-9.
49. Ruggeri l, Capanni M, Urbani E, et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 2002;295:2097-100.
50. Farag SS, Bacigalupo A, Eapen M, et al. The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry. Biol Blood Marrow Transplant 2006;12:876-84.
51. Witt CS, Christiansen FT. The relevance of natural killer cell human leucocyte antigen epitopes and killer cell immunoglobulin-like receptors in bone marrow transplantation. Vox Sang 2006;90:10-20.
52. Verheyden S, Demanet C. NK cell receptors and their ligands in leukemia. Leukemia 2008;22:249-57.
53. Goulmy E. Human minor histocompatibility antigens. Cur Opin Immunol 1996;8:75-81.
54. Goulmy E. Human minor histocompatibility antigens: new concepts for marrow transplantation and adoptive immunotherapy. Immunol Rev 1997;157:125-40.
55. Spierings E. Minor histocompatibility antigens:targets for tumour therapy and transplant tolerance. Int J Immunogene 2008;35:363-6.
56. Middleton PG, Taylor PRA, Jackson G, et al. Cytokine gene polymorphisms associating with severe acute graft versus host disease in HLA identical sibling transplants. Blood 1998;92:3943-8.
57. Dickenson AM. Non-HLA genetics and predicting outcome in HSCT. Int J Immunogenet 1998;35:375-80.